Diffuse Large B-Cell Lymphoma with Axillary Cutaneous Invasion in a HIV Positive Patient

André Dias; Filipa Saraiva; Fernando Maltez

doi:10.20344/amp.16873

Diffuse Large B-Cell Lymphoma with Axillary Cutaneous Invasion in a HIV Positive Patient

Authors

André Dias Serviço de Doenças Infecciosas. Hospital de Curry Cabral. Centro Hospitalar Universitário de Lisboa Central, EPE. Lisboa. https://orcid.org/0000-0002-4053-9575
Filipa Saraiva Serviço de Hematologia. Hospital Santo António dos Capuchos. Centro Hospitalar Universitário de Lisboa Central, EPE. Lisboa.
Fernando Maltez Serviço de Doenças Infecciosas. Hospital de Curry Cabral. Centro Hospitalar Universitário de Lisboa Central, EPE. Lisboa.

DOI:

https://doi.org/10.20344/amp.16873

Keywords:

HIV Infections, Immunoproliferative Disorders, Lymphoma, Large B-Cell, Diffuse

Abstract

N/a.

Downloads

Download data is not yet available.

References

Swerdlow SH, Campo E, Harris NL, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Lyon: IARC Press; 2017.

Gibson TM, Morton LM, Shiels MS, Clarke CA, Engels EA. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. AIDS. 2014;28:2313-8.

Navarro JT, Ribera JM. The influence of antiretroviral therapy on clinical aspects of HIV-related lymphoma. Int J Hematol Oncol. 2017;6:35-8.

Jacobson CA, Abramson JS. HIV-associated Hodgkin’s lymphoma: prognosis and therapy in the era of cART. Adv Hematol. 2012;2012:507257.

Downloads

210-211.PDF

Published

2022-06-22

How to Cite

Dias A, Saraiva F, Maltez F. Diffuse Large B-Cell Lymphoma with Axillary Cutaneous Invasion in a HIV Positive Patient. Acta Med Port [Internet]. 2022 Jun. 22 [cited 2023 Mar. 21];36(3):210-1. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/16873

Download Citation

Issue

Vol. 36 No. 3 (2023): March

Section

Medical Image

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.